GH
Insider
Gwenn Hansen
Chief Scientific OfficerGwenn Hansen (Chief Scientific Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Nurix Therapeutics, Inc. (NRIX). The largest single filing was $109K of NRIX (4,356 sh × $25.00, as filed), executed Aug 5.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$217K
shares × price, as filed
Last traded
Aug 5
Filed Aug 5
Median ADV $54.4M across their filed names
Open performance→Volume by month
Buys $0
Sells $217K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
NRIXRecent filings
NRIXSALE
Nurix Therapeutics, Inc.
View filing →
$109K4,356 sh × $25.00
Exec Aug 5
Filed Aug 5 · 6:59 PM ET NRIXSALE Nurix Therapeutics, Inc. View filing → $108K
5,394 sh × $20.00
Exec Jun 25
Filed Jun 25 · 5:30 PM ET